Nitazene Control Act of 2025
In committee: it can still change before the session ends.
- Stage
- In committee
- Started in
- House
- Sponsors
- 31
- Latest action
- Sep 16, 2025
What it does
The Nitazene Control Act of 2025 would permanently schedule the class of synthetic opioids known as nitazenes (2-benzylbenzimidazole opioids) under Schedule I of the Controlled Substances Act, including their isomers, esters, ethers, salts, and related compounds with specified structural modifications and mu-opioid receptor agonist activity. The bill affects manufacturers, distributors, researchers, and law enforcement by prohibiting unauthorized handling of these substances and requiring compliance with Schedule I regulations, such as registration and security controls. It also clarifies that any nitazene previously placed under temporary scheduling would be deemed permanently scheduled…
AI summary · The lawmakers haven’t published an official summary of this bill yet, so 52 wrote this one from the bill’s text.
Where it stands
Introduced (Done)
Committee (Current step)
Floor (Not started)
Law (Not started)
What moved
Who is involved
Sponsors
The lawmakers who put their names on it, lead sponsors first.
- Eugene Vindman
- Andy Harris
- August Pfluger
- Brandon Gill
- Brian Fitzpatrick
- Chrissy Houlahan
- Dan Goldman
- David Taylor
- Deborah Ross
- Derek Schmidt
- Donald Davis
- Glenn Thompson
- James Baird
- Joe Neguse
- Maggie Goodlander
- Maria Salazar
- Matt Van Epps
- Michael Baumgartner
- Michael Lawler
- Mike Carey
- Mike Kelly
- Pat Harrigan
- Randall Fine
- Rich McCormick
- Robert Bresnahan
- Robert Onder
- Russell Fry
- Ryan Mackenzie
- Sam Liccardo
- Susie Lee
- Thomas Suozzi
In the news
Reporting that may mention this subject. Possible matches are labeled.
Loading coverage…
Where it goes next
While a bill can still move, the questions are about people and money.